Additional Listing

RNS Number : 3723O

The MedicX Fund Limited

29 June 2010

 



For immediate release                                                                                                       29 June 2010

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Additional Listing

Application has been made for 82,497 ordinary shares of no par value in the Company ("Shares") to be admitted to the Official List of the FSA and to trading on the London Stock Exchange.  It is expected that these Shares will be admitted on 30 June 2010. The application is being made pursuant to the scrip dividend alternative in lieu of cash for the June 2010 interim dividend in respect of the quarter ended 31 March 2010.  Elections for a scrip dividend were received in respect of 3.2% of the ordinary shares in issue as at the record date of 4 June 2010. When issued, these Shares will rank pari passu with the existing ordinary shares.

A copy of the document relating to the Scrip Dividend Alternative dated 17 May 2010 is available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:

Financial Services Authority

25 The North Colonnade

Canary Wharf

London

E14 5HS 

End

For further information please contact:

Buchanan Communications                                              [phone]

Charles Ryland/George Prassas

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund                                                                  [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 55 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK. 

The Company's website address is www.medicxfund.com.

 

END

 

 

LISZMGZVKRFGGZM